Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of the American Chemical Society

• Publication date

  2007-05-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JA068965RPMID 17511455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spectrometric identification of organic compounds

  2013cited by this paper
• Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.

  2008cited by this paper
• Combating Alzheimer's disease with multifunctional molecules designed for metal passivation.

  2007cited by this paper
• High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.

  2007cited by this paper
• NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.

  2006cited by this paper
• Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement.

  2006cited by this paper
• Design of targeting ligands in medicinal inorganic chemistry.

  2006cited by this paper
• Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).

  2006cited by this paper
• A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation.

  2006cited by this paper
• Structural and thermodynamical properties of CuII amyloid-β16/28 complexes associated with Alzheimer’s disease

  2006cited by this paper
• Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner]

  2005cited by this paper
• Metal Ion-dependent Effects of Clioquinol on the Fibril Growth of an Amyloid β Peptide*

  2005cited by this paper
• The neurobiology of zinc in health and disease

  2005cited by this paper
• Catechol oxidase-like oxidation chemistry of the 1-20 and 1-16 fragments of Alzheimer's disease-related beta-amyloid peptide: their structure-activity correlation and the fate of hydrogen peroxide.

  2005cited by this paper
• Glucose transport to the brain: a systems model.

  2005cited by this paper
• Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.

  2004cited by this paper
• XSophe-Sophe-XeprView. A computer simulation software suite (v. 1.1.3) for the analysis of continuous wave EPR spectra.

  2004cited by this paper
• Iron inhibits neurotoxicity induced by trace copper and biological reductants

  2004cited by this paper
• Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.

  2004cited by this paper
• Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia

  2004cited by this paper
• Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques.

  2004cited by this paper
• Control of oxygen atom chirality and chelate ring conformation by protected/free sugar hydroxyl groups in glucose-pendant dipicolylamine-copper(II) complexes.

  2004cited by this paper
• Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes.

  2004cited by this paper
• Metals in our minds: therapeutic implications for neurodegenerative disorders.

  2004cited by this paper
• Neurodegenerative diseases and oxidative stress

  2004cited by this paper
• The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.

  2004cited by this paper
• Remarkable stereocontrol in the polymerization of racemic lactide using aluminum initiators supported by tetradentate aminophenoxide ligands.

  2004cited by this paper
• Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation*

  2003cited by this paper
• The metallobiology of Alzheimer's disease.

  2003cited by this paper
• Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study.

  2003cited by this paper
• Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters.

  2003cited by this paper
• Glycosyl Derivatives of Dopamine and l-dopa as Anti-Parkinson Prodrugs: Synthesis, Pharmacological Activity and In Vitro Stability Studies

  2003cited by this paper
• Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

  2003cited by this paper
• Stability and acidity constants for ternary ligand-zinc-hydroxo complexes of tetradentate tripodal ligands.

  2003cited by this paper
• Iron: A Pathological Mediator of Alzheimer Disease?

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Synthesis and in vitro chemical and enzymatic stability of glycosyl 3'-azido-3'-deoxythymidine derivatives as potential anti-HIV agents.

  2002cited by this paper
• Reactive oxygen species and protein oxidation in aging: a look back, a look ahead.

  2002cited by this paper
• Synthesis and solution studies of the complexes of trivalent lanthanides with the tetraazamacrocycle TETA-(PO)(2).

  2002cited by this paper
• Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

  2002cited by this paper
• Synthesis and anti-HIV activity of glucose-containing prodrugs derived from saquinavir, indinavir and nelfinavir.

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Synthesis and antiperoxidant activity of new phenolic O-glycosides.

  2001cited by this paper
• Treatment of Alzheimer’s Disease with Clioquinol

  2001cited by this paper
• Trinuclear Zn(II) and Cu(II) homo and heterotrimetallic complexes involving D-glucopyranosyl and biscarboxylate bridging ligands. A substrate binding model of xylose isomerases.

  2001cited by this paper
• Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

  2001cited by this paper
• Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

  2001cited by this paper
• 3,5-Disubstituted-4-hydroxyphenyls linked to 3-hydroxy-2-methyl-4(1H)-pyridinone: potent inhibitors of lipid peroxidation and cell toxicity.

  2000cited by this paper
• Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability.

  2000cited by this paper
• Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents.

  2000cited by this paper
• Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.

  2000cited by this paper
• Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents.

  2000cited by this paper
• The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.

  1999cited by this paper
• Antioxidant activity applying an improved ABTS radical cation decolorization assay.

  1999cited by this paper
• Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence.

  1999cited by this paper
• Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

  1999cited by this paper
• Copper, iron and zinc in Alzheimer's disease senile plaques.

  1998cited by this paper
• Antifungal nickel(II) complexes derived from amino sugars against pathogenic yeast, Candida albicans.

  1998cited by this paper
• Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis*

  1998cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

  1997cited by this paper
• Zinc-induced Alzheimer’s Aβ1–40 Aggregation Is Mediated by Conformational Factors*

  1997cited by this paper
• Assembly of Carbohydrates on a Nickel(II) Center by Utilizing N-Glycosidic Bond Formation with Tris(2-aminoethyl)amine (tren). Syntheses and Characterization of [Ni{N-(aldosyl)-tren}(H(2)O)](2+), [Ni{N,N'-bis(aldosyl)-tren}](2+) and [Ni{N,N',N"-tris(aldosyl)-tren}](2+).

  1996cited by this paper
• Aggregation and Metal‐Binding Properties of Mutant Forms of the Amyloid Aβ Peptide of Alzheimer's Disease

  1996cited by this paper
• Metal Complexes in Aqueous Solutions

  1996cited by this paper
• Synthesis of glucose-chlorambucil derivatives and their recognition by the human GLUT1 glucose transporter.

  1996cited by this paper
• Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs.

  1996cited by this paper
• Therapeutic iron chelators and their potential side-effects.

  1995cited by this paper
• Free radicals and oxidative stress : environment, drugs and food additives

  1995cited by this paper
• Growth inhibition of human tumor xenografts in nude mice by treatment with the antitumor agent 4,6-benzylidene-d1-D-glucose (P-1013).

  1995cited by this paper
• Modulation of A beta adhesiveness and secretase site cleavage by zinc.

  1994cited by this paper
• Rapid induction of Alzheimer A beta amyloid formation by zinc.

  1994cited by this paper
• The DIRDIF-94 program system

  1994cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Determination and Use of Stability Constants

  1992cited by this paper
• Intramuscular desferrioxamine in patients with Alzheimer's disease.

  1991cited by this paper
• Enzyme Activities in Relation to pH and Lactate in Postmortem Brain in Alzheimer‐Type and Other Dementias

  1990cited by this paper
• Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences.

  1990cited by this paper
• The toxic effects of desferrioxamine.

  1989cited by this paper
• Free radical intermediates during peroxidase oxidation of 2-t-butyl-4-methoxyphenol, 2,6-di-t-butyl-4-methylphenol, and related phenol compounds.

  1989cited by this paper
• The hydrolysis of cations

  1986cited by this paper
• Regional comparisons of brain glucose influx.

  1985cited by this paper
• Oxygen toxicity, oxygen radicals, transition metals and disease.

  1984cited by this paper
• Structural implications derived from the analysis of electron paramagnetic resonance spectra of natural and artificial copper proteins.

  1974cited by this paper
• Magnetism and transition metal complexes

  1973cited by this paper

• Leveraging heterocycle-fused 1,4-benzoquinone to design chemical modulators for both metal-free and metal-bound amyloid-β

  2025cites this paper
• Comprehensive Chemical Analysis of the Methyl 3-Nitrogen-2,3-Dideoxysaccharides Derivatives with d-ribo-Configuration: Synthesis, Reactivity of HIV-1 Reverse Transcriptase Inhibitors

  2025cites this paper
• A versatile biosensor for detecting Zn2 + and Cu2+ in Alzheimer's disease cells and acidic foods via RNA G-quadruplex hydrolysis.

  2025cites this paper
• Recent advances in the synthesis, catalytic, and adsorption applications of carbohydrate polymers

  2024cites this paper
• Rationally Designed Cu(I) Ligand to Prevent CuAβ-Generated ROS Production in the Alzheimer's Disease Context.

  2024cites this paper
• Targeting misfolding and aggregation of the amyloid-β peptide and mutant p53 protein using multifunctional molecules.

  2024cites this paper
• Evaluation of Anti-Alzheimer's Potential of Azo-Stilbene-Thioflavin-T derived Multifunctional Molecules: Synthesis, Metal and Aβ Species Binding and Cholinesterase Activity.

  2024cites this paper
• Synthesis and bio-activities of bifunctional tetrahydrosalen Cu (II) chelators with potential efficacy in Alzheimer's disease therapy.

  2024cites this paper
• Metal/metal oxide-carbohydrate polymers framework for industrial and biological applications: Current advancements and future directions.

  2023cites this paper
• Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation.

  2023cites this paper
• Chemical Chartographisis: a contemporary perspective in molecular design and synthesis.

  2023cites this paper
• Reduced Schiff-base derivatives to stop reactive oxygen species production by the Cu(Aβ) species: a structure–activity relationship

  2023cites this paper
• Amphiphilic Molecules Exhibiting Zwitterionic Excited-State Intramolecular Proton Transfer and Near-Infrared Emission for the Detection of Amyloid β Aggregates in Alzheimer's Disease.

  2023cites this paper
• α-Amylase inhibitor based on the copper(II) complex with 2-[(dimethylamino)methyl]arbutin ligand: synthesis, molecular docking, and in vitro assay of the inhibition type

  2023cites this paper
• Interaction studies of oxindole-derivatives with β-amyloid peptides inhibiting its aggregation induced by metal ions.

  2023cites this paper
• Multifunctional metallochaperone modifications for targeting subsite cavities in mutant p53-Y220C.

  2023cites this paper
• Terpyridine Glycoconjugates and Their Metal Complexes: Antiproliferative Activity and Proteasome Inhibition

  2023cites this paper
• Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer’s Disease

  2023cites this paper
• Aβ-Targeting Bifunctional Chelators (BFCs) for Potential Therapeutic and PET Imaging Applications

  2022cites this paper
• Azo-Stilbene and Pyridine-Amine Hybrid Multifunctional Molecules to Target Metal-Mediated Neurotoxicity and Amyloid-β Aggregation in Alzheimer's Disease.

  2022cites this paper
• Amyloid β-binding Bifunctional Chelators with Favorable Lipophilicity for 64Cu PET Imaging in Alzheimer’s Disease

  2021cites this paper
• Amyloid β-Binding Bifunctional Chelators with Favorable Lipophilicity for 64Cu Positron Emission Tomography Imaging in Alzheimer's Disease.

  2021cites this paper
• Salpyran: A Cu(II) Selective Chelator with Therapeutic Potential.

  2021cites this paper
• Benzothiazole Carboxylate Diester Bifunctional Chelators for 64Cu PET Imaging in Alzheimer’s Disease

  2021cites this paper
• A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease.

  2021cites this paper
• Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.

  2021cites this paper
• Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration

  2021cites this paper
• 2-(4-Hydroxyphenyl)benzothiazole dicarboxylate ester TACN chelators for 64Cu PET imaging in Alzheimer's disease.

  2021cites this paper
• Amyloid beta cleavage by ANA‐TA9, a synthetic peptide from the ANA/BTG3 Box A region

  2021cites this paper
• Multifunctional compounds for the treatment of Alzheimer’s disease

  2020cites this paper
• Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches

  2020cites this paper
• Recent trends and challenges on carbohydrate-based molecular scaffolding: general consideration toward impact of carbohydrates in drug discovery and development

  2020cites this paper
• Impact of sphingosine and acetylsphingosines on the aggregation and toxicity of metal-free and metal-treated amyloid-β

  2020cites this paper
• Review of comparative studies of cytotoxic activities of Pt(II), Pd(II), Ru(II)/(III) and Au(III) complexes, their kinetics of ligand substitution reactions and DNA/BSA interactions

  2020cites this paper
• Amentoflavone: A Bifunctional Metal Chelator that Controls the Formation of Neurotoxic Soluble Aβ42 Oligomers.

  2020cites this paper
• Enhancement of the Antioxidant Activity and Neurotherapeutic Features through Pyridol Addition to Tetraazamacrocyclic Molecules.

  2019cites this paper
• The theory of dove-like particles

  2019cites this paper
• Studying the reactivity of "old" Cu(II) complexes for "novel" anticancer purposes.

  2019cites this paper
• Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.

  2019cites this paper
• Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.

  2019cites this paper
• Catalytides derived from the Box A region in the ANA/BTG3 protein cleave amyloid-β fragment peptide

  2019cites this paper
• Modification of Aβ Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes

  2019cites this paper
• The Novel Catalytic Peptide, A Synthetic Nona-Peptide (JAL-TA9) Derived from Tob1 Protein, Digests the Amyloid-β Peptide

  2019cites this paper
• Comparison of the catalytic activities of 5-mer synthetic peptides derived from Box A region of Tob/BTG family proteins against the amyloid-beta fragment peptides

  2019cites this paper
• An overview on ligands of therapeutically interest

  2018cites this paper
• New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases

  2018cites this paper
• Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.

  2018cites this paper
• A small bifunctional chelator that modulates Aβ42 aggregation

  2018cites this paper
• Metal Ions and Complexes in Alzheimer's Disease: From Fundamental to Therapeutic Perspectives

  2018cites this paper
• An innovative and efficient route to the synthesis of metal-based glycoconjugates: proof-of-concept and potential applications.

  2018cites this paper
• Cu2+ selective chelators relieve copper-induced oxidative stress in vivo

  2018cites this paper
• Azo-dyes based small bifunctional molecules for metal chelation and controlling amyloid formation.

  2018cites this paper
• Hybrid Antioxidant and Metal Sequestering Small Molecules Targeting the Molecular Features of Alzheimer’s Disease

  2017cites this paper
• Poly(Zn-salphen)-alt-(p-phenyleneethynylene)s as Dynamic Helical Metallopolymers: Luminescent Properties and Conformational Behavior

  2017cites this paper
• Nouvelles preuves de concept pour la chélatothérapie contre la maladie d'Alzheimer : études spectroscopiques des interactions entre les ions cuivre et zinc

  2017cites this paper
• Metal–Carbohydrate Interactions/Complexes

  2017cites this paper
• Evaluation of 64Cu-Based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer’s Disease

  2017cites this paper
• Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level

  2017cites this paper
• Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc01269a Click here for additional data file.

  2017cites this paper
• An Overview of Multifunctional Metal Chelators as Potential Treatments for Neurodegenerative Diseases

  2017cites this paper
• Coordination Chemistry of Bifunctional Chemical Agents Designed for Applications in 64Cu PET Imaging for Alzheimer’s Disease

  2017cites this paper
• Sugar-metal ion interactions: The coordination behavior of cesium ion with lactose, d-arabinose and l-arabinose

  2016cites this paper
• New Hydroxyquinoline‐Based Derivatives as Potent Modulators of Amyloid‐β Aggregations

  2016cites this paper
• How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study

  2016cites this paper
• Importance of the Dimethylamino Functionality on a Multifunctional Framework for Regulating Metals, Amyloid-β, and Oxidative Stress in Alzheimer's Disease.

  2016cites this paper
• Ionophoric polyphenols selectively bind Cu(2+), display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila.

  2016cites this paper
• Ultraviolet irradiation-mediated formation of Aβ42 oligomers and reactive oxygen species in Zn2+-bound Aβ42 aggregates irrespective of the removal of Zn2+

  2016cites this paper
• Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.

  2015cites this paper
• Modulation of 14C‐labeled glucose metabolism by zinc during aluminium induced neurodegeneration

  2015cites this paper
• Ultraviolet light triggers the conversion of Cu2+-bound Aβ42 aggregates into cytotoxic species in a copper chelation-independent manner

  2015cites this paper
• Self-Targeting Fluorescent Carbon Dots for Diagnosis of Brain Cancer Cells.

  2015cites this paper
• Entasis through hook-and-loop fastening in a glycoligand with cumulative weak forces stabilizing Cu(I).

  2015cites this paper
• Design and synthesis of sugar-triazole based uracil appended sugar-imine derivatives – an application in DNA binding studies

  2015cites this paper
• Effects of aluminum on amyloid-beta aggregation in the context of Alzheimer’s disease

  2015cites this paper
• Sialic Acid Hydroxamate: A Potential Antioxidant and Inhibitor of Metal‐Induced β‐Amyloid Aggregates

  2015cites this paper
• Sugar conjugates of 3-hydroxy-4-pyridinones : synthesis and investigations into their potential for drug delivery to the brain

  2015cites this paper
• Thioflavin-based molecular probes for application in Alzheimer's disease: from in silico to in vitro models.

  2015cites this paper
• Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity

  2014cites this paper
• Metallothioneins and synthetic metal chelators as potential therapeutic agents for removal of aberrant metal ions from metal-Aβ species.

  2014cites this paper
• Disaggregation ability of different chelating molecules on copper ion-triggered amyloid fibers.

  2014cites this paper
• 3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents.

  2014cites this paper
• 8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation.

  2014cites this paper
• Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease

  2014cites this paper
• Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease.

  2014cites this paper
• Exploiting the therapeutic potential of 8-β-d-glucopyranosylgenistein: synthesis, antidiabetic activity, and molecular interaction with islet amyloid polypeptide and amyloid β-peptide (1-42).

  2014cites this paper
• Metal Complexes of Carbohydrate‐targeted Ligands in Medicinal Inorganic Chemistry

  2014cites this paper
• Highly dispersed photoactive zinc oxide nanoparticles on mesoporous phosphonated titania hybrid

  2014cites this paper
• Interaction and reactivity of synthetic aminoisoflavones with metal-free and metal-associated amyloid-β

  2014cites this paper
• Neuroprotective Role of a Novel Copper Chelator against Aβ 42 Induced Neurotoxicity

  2013cites this paper
• Sugar-metal ion interactions: the complicated coordination structures of cesium ion with D-ribose and myo-inositol.

  2013cites this paper
• Sequence Determination of a Novel Tripeptide Isolated from the Young Leaves of Azadirachta indica A. Juss

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

  2013cites this paper
• The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity.

  2013cites this paper
• Synthesis, structure, and conformational mobility of a vaulted trans-bis(o-aminophenolato)platinum(II) complex

  2013cites this paper
• Complexation between Cu(II) and curcumin in the presence of two different segments of amyloid β.

  2013cites this paper
• Copper and heme-mediated Abeta toxicity: redox chemistry, Abeta oxidations and anti-ROS compounds.

  2013cites this paper
• Diagnostic imaging agents for Alzheimer's disease: copper radiopharmaceuticals that target Aβ plaques.

  2013cites this paper
• Werner coordination chemistry and neurodegeneration.

  2013cites this paper
• Inhibition of human prion neuropeptide PrP106-126 aggregation by hexacoordinated ruthenium complexes.

  2013cites this paper
• Multifunctional ligands in medicinal inorganic chemistry--current trends and future directions.

  2012cites this paper